Glutamine

Glutamine

SCHEMBL6002608

CC(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)O.NC(=O)CCC(N)C(=O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
ALOX15 P16050 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
NOD1 Q9Y239 5/20 0.50
DPP4 P27487 1/20 0.44
DPP8 Q6V1X1 1/20 0.44
DPP9 Q86TI2 1/20 0.44
GNPAT O15228 1/20 0.40
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
CYP1A2 P05177 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamine SCHEMBL6002605 1.00 KMT2A (0.53) KMT2AALOX15BLMPMP22NOD1
SCHEMBL156956 0.93 GNPAT (0.44) KMT2AALOX15BLMNOD1DPP4
SCHEMBL15017971 0.93 GNPAT (0.44) KMT2AALOX15BLMNOD1DPP4
SCHEMBL19177222 0.93 GNPAT (0.44) KMT2AALOX15BLMNOD1DPP4
SCHEMBL156957 0.93 GNPAT (0.44) KMT2AALOX15BLMNOD1DPP4
Glutamine SCHEMBL8764303 0.88 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL8764292 0.88 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL8764294 0.88 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL29150368 0.88 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
SCHEMBL30525295 0.87 DPP4 (0.55) KMT2AALOX15BLMPMP22NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507276-B2 Tissue culture media used as a component of cosmetics LA PRAIRIE GROUP AG (CH) 2013-08-13 US disclosed
US-20060182701-A1 Tissue culture media used as a component of cosmetics JUVENA (INTERNATIONAL) AG, (CH) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060182701-A1 Tissue culture media used as a component of cosmetics CUTA, NEFM, MITF KMT2A 1937/4885ALOX15 387/4885BLM 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.